Log in
Enquire now
‌

US Patent 7282502 CCR9 inhibitors and methods of use thereof

Patent 7282502 was granted and assigned to Millennium Pharmaceuticals on October, 2007 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Millennium Pharmaceuticals
Millennium Pharmaceuticals
0
Date Filed
March 28, 2006
0
Date of Patent
October 16, 2007
0
Patent Application Number
11391633
0
Patent Inventor Names
Chen Shaowu
0
Geraldine C. B. Harriman
0
Paul Fleming
0
Zhan Shi
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
7282502
0
Patent Primary Examiner
‌
Venkataraman Balasubramanian
0

Find more entities like US Patent 7282502 CCR9 inhibitors and methods of use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.